Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Oct 2025 for Cocrystal Pharma, Inc., €4,292.
Filing timeline
BuySaleJames Joseph Martin
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
James Joseph Martin: trading record in brief
James Joseph Martin (board member) discloses dealings in 2 companies, chiefly Cocrystal Pharma, Inc. and PetVivo Holdings, Inc. Over a trading history stretching from 12 March 2021 to 28 October 2025, the count stands at 4 filings.
The open-market record is one-sided, with 1 purchase worth €17k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants.
Most recently, on 30 October 2025, the filings show a share grant worth €4,292 in Cocrystal Pharma, Inc. The last purchase on record was published on 26 May 2021, which is 1,977 days ago. Filings reach the SEC (Form 4) feed a median of 13 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James Joseph Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,598 shares@ US$1.39100.0% of flowCommon StockSEC:0001493152-25-020218:0
40,000 sharesCommon StockSEC:0001493152-24-040900:0
3,000 shares@ US$7.00100.0% of flowCommon StockSEC:0001493152-21-012958:0
Canonical exit: 23 Jul 2021 (T+90)
3 of 3 declarations
